FCM
MDT icon

Fieldview Capital Management’s Medtronic MDT Stock Holding History

Fieldview Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-9,543
Closed -$917K – 638
2025
Q4 		$917K Buy
+9,543
New +$927K 0.16% 191
2025
Q2 		– Sell
-40,362
Closed -$3.63M – 455
2025
Q1 		$3.63M Sell
40,362
-59,426
-60% -$5.32M 0.51% 58
2024
Q4 		$7.97M Buy
+99,788
New +$8.64M 1.23% 4

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fieldview Capital Management's MDT Position: Q1 2026 in Review

Fieldview Capital Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 9,543 shares — an estimated $917K sold.

Fieldview Capital Management first reported a position in MDT in Q4 2024 and held it in 3 quarters. The position peaked at $7.97M in Q4 2024. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Fieldview Capital Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
  • Fieldview Capital Management sold 9,543 Medtronic shares in Q1 2026, an estimated $917K.
  • Fieldview Capital Management first reported a position in Medtronic in Q4 2024 and held it in 3 quarters.
  • Fieldview Capital Management's Medtronic position peaked at $7.97M in Q4 2024.
  • 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Fieldview Capital Management's 13F filing for Q1 2026, filed 14 May 2026.